Mission
The National Center for Regenerative Medicine (NCRM) is a platform to facilitate translational research, clinical application, and commercialization of regenerative medicine, tissue engineering, and stem cell therapeutics across a consortium of institutions. NCRM is driven by three nationally ranked medical research powerhouses—Case Western Reserve University, Cleveland Clinic, MetroHealth Medical Center, and University Hospitals. Through this network of researchers and clinicians, research discoveries are actively being translated into cell-based therapies for patient care.
Vision
The National Center for Regenerative Medicine establishes Northeast Ohio as a global leader in regenerative medicine and cellular therapy. By advancing stem cell research, gene and lentiviral vector design, cellular manufacturing, and clinical trials; and by building strong partnerships with academic and biotechnology leaders worldwide.
Goals of the NCRM
Translational Research: To support stem cell and regenerative medicine research across various disciplines, institutions, and commercial entities.
Education and Training: To develop cutting-edge education programs for researchers, clinicians, trainees, and the general public.
Strategic Partnership: To build networks across academic, clinical, commercial, and public sectors.
Commercialization: To translate innovative technologies and cell therapies into business opportunities.